Search

Comprehensively reversed disease progression symptoms in a CMT mice model.

The results from APRIL study, previously presented at the International Stroke Conference 2023, indicate that ApTOLL showed good safety in 151 acute ischemic stroke patients.

In 2021, the impact on GDP of biotech companies amounted to €11,183 million, or 1% of GDP

On European Skin Cancer Prevention Day, we talk to Almirall, Platinum Sponsor of BIOSPAIN2023, about the importance of prevention and the main risk factors

ZIP Solutions (Barcelona), a 100% affiliate of Biat Group (ticker BST), and YIMA, a Cyagen-owned AI-enabled biotech company, are please to announce a strategic co-marketing agreement for gene therapy.

For World Environment Week, AseBio is analysing the role of biotechnology in tackling the challenges of the agrifood system, one of the main goals of BIOSPAIN 2023

BIOLAN is currently part of the AQUAVITAE project, funded by the European Commission and which main objective is to perform high quality research in the aquaculture field

Following the acquisitions of DS InPharmatics (DSI) in 2021 and Zwiers Regulatory Consultancy in 2022, ProductLife Group (PLG), a global provider of regulatory and compliance services to the life

Meet Telum Therapeutics, our new member. We talked to Roberto Díez-Martínez, CEO y co- founder of the company.

Over 30 innovative biotech companies possess the comprehensive capabilities to develop advanced therapies, from initial R&D through manufacturing, efficient transfer and distribution